Evidence map›Paper›PMID 33916883›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Gingival Crevicular Placental Alkaline Phosphatase Is an Early Pregnancy Biomarker for Pre-Eclampsia.

Alejandra Chaparro, Maximiliano Monckeberg, Ornella Realini, Marcela Hernández, Fernanda Param, Daniela Albers, Valeria Ramírez, Juan Pedro Kusanovic, Roberto Romero, Gregory Rice and 1 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Alejandra ChaparroCentre for Biomedical and Innovation Research, Department of Periodontology, Faculty of Dentistry, Universidad de Los Andes, Santiago 7620001, Chile.ORCID 0000-0003-0791-7746
Maximiliano MonckebergDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universidad de Los Andes, Santiago 7620001, Chile.
Ornella RealiniCentre for Biomedical and Innovation Research, Department of Periodontology, Faculty of Dentistry, Universidad de Los Andes, Santiago 7620001, Chile.
Marcela HernándezLaboratory of Periodontal Biology, Department of Pathology, Faculty of Dentistry, Universidad de Chile, Santiago 8330015, Chile.ORCID 0000-0001-8289-7314
Fernanda ParamCentre for Biomedical and Innovation Research, Department of Periodontology, Faculty of Dentistry, Universidad de Los Andes, Santiago 7620001, Chile.ORCID 0000-0001-5426-0551
Daniela AlbersDepartment of Statistics, Faculty of Dentistry, Universidad Mayor, Santiago 8580745, Chile.
Valeria RamírezDepartment of Public Health and Epidemiology, Faculty of Dentistry, Universidad de los Andes, Santiago 7620001, Chile.
Juan Pedro KusanovicDepartment of Obstetrics and Gynecology, Hospital Sótero del Río, Santiago 13201, Chile.
Roberto RomeroPerinatology Research Branch, NICHD/NIH/DHHS, Detroit, MI 48201, USA.
Gregory RiceCenter for Research and Medical Innovation, Department of Obstetrics and Gynecology, Faculty of Medicine, Universidad de Los Andes, Santiago 7620001, Chile.
Sebastián E IllanesDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universidad de Los Andes, Santiago 7620001, Chile.
Universidad de Los Andes, Chile · CLPontificia Universidad Católica de Chile · CLThe University of Queensland · AUUnited States Department of Health and Human Services · USUniversidad Mayor · CLUniversity of Chile · CL

Funding

Fondo de Fomento al Desarrollo Científico y Tecnológico ID16I10452NICHD NIH HHS HHSN275201300006C
6 · The paper itself

Abstract

Early and innovative diagnostic strategies are required to predict the risk of developing pre-eclampsia (PE). The purpose of this study was to evaluate the performance of gingival crevicular fluid (GCF) placental alkaline phosphatase (PLAP) concentrations to correctly classify women at risk of PE. A prospectively collected, retrospectively stratified cohort study was conducted, with 412 pregnant women recruited at 11-14 weeks of gestation. Physical, obstetrical, and periodontal data were recorded. GCF and blood samples were collected for PLAP determination by ELISA assay. A multiple logistic regression classification model was developed, and the classification efficiency of the model was established. Within the study cohort, 4.3% of pregnancies developed PE. GCF-PLAP concentration was 3- to 6-fold higher than in plasma samples. GCF-PLAP concentrations and systolic blood pressure were greater in women who developed PE (

Indexed as

cohort studygestationplacental biomarkerspre-eclampsiarisk prediction model

Identifiers

PMID33916883
PMCPMC8067553
OpenAlexW3144111439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.